# Patrick B. Mark

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/patrick-b-mark/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,649 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 70 |
| i10-index | 238 |
| Last Known Institution | Queen Elizabeth University Hospital |
| OpenAlex ID | https://openalex.org/A5042828582 |
| ORCID iD | 0000-0003-3387-2123 |
| Works | 545 |

## Researcher papers

Showing 12 of 19.

- [Chronic Kidney Disease and Coronary Artery Disease](https://scholariq.org/papers/chronic-kidney-disease-and-coronary-artery-disease/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/heart-failure-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)](https://scholariq.org/papers/effect-of-empagliflozin-on-left-ventricular-volumes-in-patients-with-type-2/)
- [Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial](https://scholariq.org/papers/intravenous-ferric-derisomaltose-in-patients-with-heart-failure-and-iron/)
- [Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes](https://scholariq.org/papers/estimated-glomerular-filtration-rate-albuminuria-and-adverse-outcomes/)
- [Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association](https://scholariq.org/papers/cardiovascular-complications-in-chronic-kidney-disease-a-review-from-the/)
- [Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study](https://scholariq.org/papers/prevalence-outcomes-and-cost-of-chronic-kidney-disease-in-a-contemporary/)
- [Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort](https://scholariq.org/papers/gadolinium-enhanced-mr-imaging-and-nephrogenic-systemic-fibrosis-retrospective/)
- [Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease](https://scholariq.org/papers/glomerular-filtration-rate-by-differing-measures-albuminuria-and-prediction-of/)
- [Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/chronic-kidney-disease-and-arrhythmias-conclusions-from-a-kidney-disease/)
- [Lipid management in patients with chronic kidney disease](https://scholariq.org/papers/lipid-management-in-patients-with-chronic-kidney-disease/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Researcher university

- [Queen Elizabeth University Hospital](https://scholariq.org/institutions/queen-elizabeth-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
